Doctors break down the biggest potential medication and coffee interactions to know—ranging from significant interactions to ...
A phase 2 trial suggests that the novel SNRI ammoxetine may effectively treat major depressive disorder while avoiding some side effects common to other antidepressants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback